Industry News
PETA Involvement Helped Cut Number Of Animals Used In HPV Chemicals Challenge Program From 3.5 Million To 127,000
Oct 04, 2012
In an article published in the peer-reviewed journal Environmental Health Perspectives (EHP), People for the Ethical Treatment of Animals reports that the U.S. Environmental Protection Agency (EPA) High Production Volume (HPV) Chemicals Challenge Program had the potential to use 3... Read More
For Cord Blood Cell Transplantation After Stoke, Therapeutic Time Window An Important Factor
Oct 04, 2012
A research team from Germany has found that optimal benefit and functional improvement for ischemic stroke results when human umbilical cord blood mononuclear cells (hUCB MNCs) are transplanted into rat stroke models within 72 hours of the stroke. Their study is published in the current issue of Cell Transplantation (21:6), now freely available on-line... Read More
IU Research Finds Memory, Thought-Process Training Promising Options For Breast Cancer Symptom Management
Oct 04, 2012
A new Indiana University study is the first of its kind to show it may be possible to improve memory and thought process speed among breast cancer survivors. Diane M. Von Ah, Ph.D., R.N... Read More
New Treatment And Hope For Ovarian Cancer Patients
Oct 04, 2012
Ovarian cancer can be treated by a newly discovered type of drug that reduces the number of doses the patients need to take, and is also effective for those whose cancer has become drug-resistant. The treatment was discovered by a team at USC and has been tested on mice tumors and on ovarian cancer cells. The finding was published in the Proceedings of the National Academy of Sciences (PNAS)... Read More
Trial Of Genetically Engineered Immune System To Fight Melanoma
Oct 04, 2012
Loyola University Medical Center has launched the first clinical trial in the Midwest of an experimental melanoma treatment that genetically engineers a patient's immune system to fight the deadly cancer. A batch of the immune system's killer T cells will be removed from the patient and genetically modified in a Loyola lab... Read More
New Targeted Therapy Indicated By Breakthrough In Understanding Lung Cancer Vulnerabilities
Oct 04, 2012
More effective treatments for one of the deadliest forms of cancer are one step closer thanks to groundbreaking research from an international collaborative study... Read More
Improving Stem Cell Transplant Outcomes By Harnessing The Immune System
Oct 04, 2012
A novel therapy in the early stages of development at Virginia Commonwealth University Massey Cancer Center shows promise in providing lasting protection against the progression of multiple myeloma following a stem cell transplant by making the cancer cells easier targets for the immune system... Read More
New Colonoscopy Surveillance Guidelines Issued By GI Societies
Oct 04, 2012
Patients at average risk of colorectal cancer who have a clean colonoscopy do not need to repeat the test for 10 years. This and many other practical recommendations for cancer prevention were issued in "Guidelines for Colonoscopy Surveillance After Screening and Polypectomy,"1 a consensus update issued by the U.S. Multisociety Task Force on Colorectal Cancer... Read More
PETA Involvement Helped Cut Number Of Animals Used In HPV Chemicals Challenge Program From 3.5 Million To 127,000
Oct 04, 2012
In an article published in the peer-reviewed journal Environmental Health Perspectives (EHP), People for the Ethical Treatment of Animals reports that the U.S. Environmental Protection Agency (EPA) High Production Volume (HPV) Chemicals Challenge Program had the potential to use 3... Read More
Early Response To Treatment For Head And Neck Cancer Patients Predicted By PET
Oct 04, 2012
Determining the optimal treatment course and predicting outcomes may get easier in the future for patients with head and neck sqaumous cell carcinomas (HNSCCs) with the use of an investigational imaging agent... Read More
Previous Page Next Page